A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can significantly improve—and in some cases even reverse—advanced liver disease. The findings come from the ESSENCE Phase III clinical trial,

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of researchers has now discovered it can also do wonders for people who have developed liver disease.